VELLANKI AVANISH (President and CEO) exercised options at RAIN ONCOLOGY INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 3/15/2022ACC: 0000899243-22-011033
DirectorOfficer· President and CEO
Since Apr 2021
0.00
Net shares
Net seller
$57.9K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
14.47K acquired · 14.47K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+14.47K
Price / share
$4.00
Trade value
$57.87K
% of position
0.5%
3/11/2022
2.82M→2.84M
Total
Net shares
+14.47K
Net value
$57.87K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/11/2022 | M · Option Exercise | +14.47K | $4.00 | $57.87K | 0.5% | 2.82M | 2.84M |
| Total | +14.47K | $57.87K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
14.47K shares
Shares
−14.47K
Strike price
4.00
Held after
31.83K
Exercisable
—
3/11/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock14.47K shares | 3/11/2022 | M · Option Exercise | −14.47K | 4.00 | — | 31.83K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned138.90K
Total
138.90K indirect138.90K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 138.90K | Indirect |
| Total | 138.90K | 138.90K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported